Metraipolis › archive › dc_2408bd07da4d

Identification of galangin as a therapeutic candidate for primary biliary cholangitis via systematic druggable genome-wide Mendelian randomization analysis… — Europe PMC PMID:41142241

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41142241
DOI
10.3389/fphar.2025.1674693
License (as archived)
solo-consultazione
Archived
2026-11-09T11:08:41.265Z
SHA-256 of the archived text
0f5c6015f877d7c135104182d870f083586fc7ec35a43992e60353e573d83604
Stable URL of this page
https://metraipolis.com/documento/dc_2408bd07da4d

How to cite

Identification of galangin as a therapeutic candidate for primary biliary cholangitis via systematic druggable genome-wide Mendelian randomization analysis… — Europe PMC PMID:41142241 — Europe PMC (en), https://europepmc.org/article/MED/41142241 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2408bd07da4d (Metraipolis archive dc_2408bd07da4d, sha256 0f5c6015f877d7c135104182d870f083586fc7ec35a43992e60353e573d83604)
BibTeX
@misc{dc2408bd07da4d,
  title = {Identification of galangin as a therapeutic candidate for primary biliary cholangitis via systematic druggable genome-wide Mendelian randomization analysis… — Europe PMC PMID:41142241},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41142241},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2408bd07da4d; sha256 0f5c6015f877d7c135104182d870f083586fc7ec35a43992e60353e573d83604},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41142241. Agents can read the archived copy with the MCP tool read_document.